World Cervical Cancer Elimination Day Highlights Need for Screening

The CSR Journal Magazine

World Health Organisation data indicates that one in every five women diagnosed with cervical cancer is from India. Despite this alarming statistic, only 1.9 per cent of women aged 30 to 49 have undergone cervical cancer screening, according to the National Family Health Survey-5. This low screening rate raises concerns about awareness and access to preventive healthcare.

Dr Amit Upadhyay, a senior consultant hematologist and oncologist at PSRI Hospital in Delhi, notes that many women typically consult a gynaecologist only when experiencing pain, abnormal bleeding, or during pregnancy. This limited approach to healthcare contributes to the low rates of screening for cervical cancer.

Additionally, societal stigma surrounding the Human Papillomavirus (HPV), a sexually transmitted infection linked to cervical cancer, discourages many women from seeking tests. Women often fear being judged or mistakenly believe that undergoing screening suggests promiscuity or infidelity. Such misconceptions hinder proactive health measures.

Understanding Screening Guidelines

Dr Mandeep Singh Malhotra, an oncologist at Art of Healing Cancer in Gurugram, emphasises that cervical cancer screening should commence at the age of 25 and continue until the age of 65. Various methods are available for screening, including HPV testing, Pap smears, and Visual Inspection with Acetic Acid (VIA).

HPV testing can be conducted every five years, either on its own or alongside a Pap smear, which can be repeated every three years if HPV testing is not accessible. Under India’s national screening programme, women aged 30 to 65 are offered VIA every five years at government health facilities, ensuring that more women have access to crucial screening services.

HPV self-sampling is also emerging as a viable option for women who may feel uncomfortable with clinical examinations. This innovation aims to increase participation in screening and improve overall health outcomes.

Innovations and Recommendations for Screening

Veena Moktali, co-founder of Smart Scope CX by Periwinkle Technologies, highlights the importance of accessible screening options. The organisation has developed a technology that allows nurse-midwives in village clinics to conduct cervical cancer screenings in under 60 seconds. This initiative has reportedly screened lakhs of women both in India and internationally.

During the BRICS Summit in 2026, this innovation was presented to prominent leaders, including Indian Prime Minister Narendra Modi, Chinese President Xi Jinping, and Russian President Vladimir Putin, showcasing its potential impact on global health.

Women are advised to schedule their screening mid-cycle, ideally between days 10 and 20 of their menstrual cycle, and to refrain from intercourse 48 hours prior to the test. It is also recommended to avoid tampons, vaginal creams, and other products for 48 hours before screening. Mentioning any symptoms of infection is crucial, as these may need to be addressed before the screening can take place.

While India’s national HPV vaccination campaign, launched in February 2026, offers free vaccination to 14-year-old girls, it is important to note that vaccination does not replace the need for regular screening. Available vaccines do not protect against all cancer-causing HPV types, and early-stage cervical cancer often presents no symptoms. Routine screening remains essential, as precancerous changes can take 10 to 15 years to develop into cancer.

Long or Short, get news the way you like. No ads. No redirections. Download Newspin and Stay Alert, The CSR Journal Mobile app, for fast, crisp, clean updates!

App Store – https://apps.apple.com/in/app/newspin/id6746449540

Google Play Store – https://play.google.com/store/apps/details?id=com.inventifweb.newspin&pcampaignid=web_share

Latest News

Popular Videos